Fig. 2From: Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulationSurvival plots for patients in the propensity score-matched combination therapy and monotherapy groups. The 28-day survival rate was significantly higher in the combination therapy group (79.8%) than in the monotherapy group (70.0%) (P = 0.014, log-rank test). Hazard ratio 0.55 (0.34–0.89). Back to article page